We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PTIX market cap is 1.6M. The company's latest EPS is USD -0.7342 and P/E is -0.29.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.21M | -1.74M | -1.67M | -652k | -1.64M |
| Net Income | -1.68M | -1.72M | -1.61M | -641k | -1.55M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.55M | -4.14M | -3.56M | -4.53M | -5.7M |
| Net Income | -2.55M | -4.52M | -3.56M | -5M | -5.53M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.32M | 2.58M | 1.47M | 1.51M | 1.96M |
| Total Liabilities | 655k | 447k | 674k | 789k | 943k |
| Total Equity | 3.67M | 2.13M | 793k | 719k | 1.01M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 879k | 11.06M | 8.04M | 4.32M | 1.96M |
| Total Liabilities | 2.03M | 1.12M | 1.12M | 655k | 943k |
| Total Equity | -1.15M | 9.94M | 6.92M | 3.67M | 1.01M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.7M | -1.66M | -3.21M | -3.4M | -4.22M |
| Investing | 4.78M | 1.2M | 2.8M | 2.8M | 2.8M |
| Financing | N/A | N/A | 45k | 361k | 1.96M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.35M | -2.8M | -1.99M | -3.7M | -4.22M |
| Investing | N/A | -9.91M | 1.6M | 4.78M | 2.8M |
| Financing | 1.22M | 12.58M | N/A | N/A | 1.96M |
| Market Cap | 1.6M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.86 |
| Price to Book Ratio | 1.56 |
| Dividend Yield | - |
| Shares Outstanding | 7.53M |
| Average Volume (1 week) | 212.05k |
| Average Volume (1 Month) | 10.93M |
| 52 Week Change | -85.87% |
| 52 Week High | 1.87 |
| 52 Week Low | 0.179 |
| Spread (Intraday) | 0.01 (3.69%) |
| Company Name | Protagenic Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.protagenic.com |
| Industry | books: pubg, pubg & printing (2731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
